Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Molecular and Cellular Endocrinology|November 15, 2002
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approachesR J A van Moorselaar, E E VoestNederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Androgen receptor inhibitors in prostate cancer: new drugs, but for which patient?]André N Vis, R J A van MoorselaarEuropean Urology Focus|December 25, 2017
Case Presentation: Botox Versus Nerve StimulationR J A van Moorselaar, Jakko A NieuwenhuijzenNederlands Tijdschrift Voor Geneeskunde|May 5, 2016
[Introduction of PSMA PET requires thorough research]Theo M de Reijke, Jeroen R J A van MoorselaarNederlands Tijdschrift Voor Geneeskunde|June 13, 2002
[Persistent renal bleeding treated with selective vascular embolisation with preservation of renal function]R Lazarov, G A P de Kort, R J A van MoorselaarBritish Journal of Cancer|November 22, 2012
A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisI V Bijnsdorp, L Rozendaal, R J A van Moorselaar, et al.BJU International|December 12, 2007
How quality influences the clinical outcome of external beam radiotherapy for localized prostate cancerMarco van Vulpen, Uulke A van der Heide, Jeroen R J A van MoorselaarJournal of Cancer Research and Clinical Oncology|May 24, 2007
New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migrationA J M Mol, A A Geldof, G A Meijer, et al.Current Urology|June 12, 2014
The use of a memokath prostatic stent for obstructive voiding symptoms after brachytherapyG W de Graaf, P E F Stijns, W A Scheepens, et al.European Urology|June 20, 2003
Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapyM C M Grimbergen, C F P van Swol, T G N Jonges, et al.Pageof 5